JustusJohnFiechtnerMDMPH

Rheumatology • Lansing, MI

Justus Fiechtner, MD, PLLC 3394 E Jolly Rd, Ste C Lansing, MI 48910

Join to view full profile

Dr. Fiechtner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fiechtner's full profile

Already have an account?

Office
3394 E Jolly Rd
Ste C
Lansing, MI 48910
Phone+1 517-272-9700

Fax+1 517-272-9706

Education & Training

University of WashingtonFellowship, Rheumatology, 1978 - 1980
US Naval HospitalInternship, Transitional Year, 1972 - 1973
Boston University School of MedicineClass of 1972
Marshfield ClinicResidency, Internal Medicine

Certifications & Licensure

CA State Medical License 1973 - Present
MI State Medical License 1991 - 2028
AZ State Medical License 2018 - 2025
HI State Medical License 1995 - 2020
ND State Medical License 2018 - 2019
MN State Medical License 1984 - 1990
WA State Medical License 1978 - 1981
WI State Medical License 1975 - 1981
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology
Join now to see all

Awards, Honors, & Recognition

Fellow (FACR) American College of Rheumatology

Clinical Trials

A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis Start of enrollment: 2005 Dec 01
Terminated
Phase 2
Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis Start of enrollment: 2007 Nov 06
Terminated
Phase 2
Masitinib in Refractory Active Rheumatoid Arthritis Start of enrollment: 2011 Jul 01
Terminated
Phase 2, Phase 3
Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus Start of enrollment: 2012 Oct 01
Completed
Phase 4
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
Completed
Phase 3
Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis Start of enrollment: 2013 Jul 01
Unknown status
Phase 4
Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis Start of enrollment: 2015 Feb 21
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
A Patient With Rheumatoid Arthritis on Methotrexate and Etanercept Who Developed Pasteurella multocida Bacteremia.
Jessica Baer Mears, Long Huynh-Duc, Justus J. Fiechtner
Journal of Clinical Rheumatology. 2015-12-01
39 citations
Patient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physician.
Richard J. Martin, Andrew J Head, Jonathan René, Timothy J Swartz, Justus J Fiechtner
The Journal of Rheumatology. 2008-04-01
8 citations
Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-co...
Allan Gibofsky, Jude Rodrigues, Justus J Fiechtner, Manuela F. Berger, Sharon Pan
Clinical Therapeutics. 2007-06-01

Professional Memberships

American College of Rheumatology - ACR
Fellow